Ranofy Biotech

Ranofy Biotech is a pioneering biotechnology company focused on the therapeutic potential of RNA-binding proteins (RBPs) to treat cancer and other life-threatening conditions. The company utilizes a proprietary platform designed to identify and optimize small molecule modulators that can disrupt or enhance RBP-RNA interactions, a field traditionally considered difficult to drug. By integrating structural biology, high-throughput screening, and deep RNA expertise, Ranofy aims to develop a robust pipeline of first-in-class precision medicines. Headquartered in Suzhou, China, the firm is backed by prominent life science investors and led by a team of experts in RNA science and drug discovery. The company's approach targets the underlying drivers of disease at the post-transcriptional level, offering new hope for patients with limited treatment options.